Navigation Links
Benefits from Radiation Therapy Outweigh Risks for Cancer Patients

THE WOODLANDS, Texas, Jan. 25 /PRNewswire/ -- In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.

Cancer is a serious and potentially life-threatening disease. Radiation therapy is one of the safest, most effective ways to treat this disease. About half of all people with cancer are treated with radiation therapy, either alone or in combination with other types of cancer treatment.

US Oncology is affiliated with a network of more than 1,300 physicians, including more than 160 radiation oncologists. As technology advances, so does the care required by the technical team to ensure patient safety. US Oncology affiliated practices that offer radiation therapy services are led by board certified radiation oncology physicians and a highly trained technical staff. Quality assurance and patient safety are taken very seriously. Throughout the US Oncology network, steps are taken on a daily basis to ensure that each and every treatment is delivered as intended by the physician. 

Practices across the entire US Oncology network follow published guidelines from the American Association of Physicists in Medicine on the performance testing of all radiation therapy technology, comply with regulatory requirements, and engage in a radiation oncology peer-review program that includes a focus on quality assurance.

For more information, or questions about the overall safety and efficacy of radiation and other cancer therapies, please contact Jennifer Horspool, 281-863-6739,

About US Oncology

US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system—from drug development to distribution and outcomes measurement—enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site,

SOURCE US Oncology, Inc.



SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
4. Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
5. New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
6. Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
7. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
8. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
9. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
10. Studies Point to Benefits of Personalized Chemotherapy Dose Management in Colorectal Cancer
11. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
Breaking Medicine News(10 mins):